Delivery Order SPE2DB22D2007-SPE2DB24FJ3DD

Award Date 6/5/24
Potential Completion Date 6/27/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,971.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200-unit vials of the prescription drug Botox. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200-unit vials of the drug Botox. The $14,553.25 fixed-price contract, awarded on July 8, 2024, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
This federal contract award, valued at $61,123.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract provides for the delivery of 200 unit vials of Botox to support the agency's medical supply requirements. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical...
This federal contract award, valued at $17,095.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This larger IDC...
The U.S. government awarded a delivery order contract valued at $17,463.90 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of BOTOX 200 unit vials to the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense (DoD) healthcare system. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, to provide a comprehensive range of...
This federal contract award, valued at $17,095.80, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a pharmaceutical product, with a final completion date of February 5, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award is for the delivery of BOTOX 200 unit vials to the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $23,285.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a...
This federal contract award is for the delivery of BOTOX 200 unit vials to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $3,492.78 and is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Botox 200 unit vials to the U.S. government. The contract, valued at $11,642.60, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, holding a $999,999,999.00 Indefinite...
This federal contract award is for the delivery of 200-unit vials of the pharmaceutical product BOTOX to the Defense Logistics Agency (DLA). The $13,971.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on July 31, 2024, with an ultimate completion date of August 21, 2024. The contract is not designated as a set-aside. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3DD
    Delivery Order

This federal contract award, valued at $14,553.25, was issued to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA). The contract is for the delivery of 200-unit vials of Botox, a prescription pharmaceutical product.

The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

The contract does not utilize a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitiveness in the federal pharmaceutical supply market. As a major pharmaceutical distribution company, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts, including those with the Department of Defense and Department of Veterans Affairs.

Generated 9/4/24, 9:23 AM